Infections by variant of concern and clades and variant of interest in the major MENA regions
| Region | χ2 (p value) | |||
| Middle east | North africa | Fragile and conflict-affected | ||
| No (row %) (column %) | No (row %) (column %) | No (row %) (column %) | ||
| Variants of concern (VOC) | ||||
| Alpha (B.1.1.7) | 0 | 70 (2.20) (44.30) | 693 (21.8) (88.8) | 2790.6 (<0.0001) |
| Beta (B.1.351) | 1139 (96.20) (2.8) | 40 (3.40) (25.3) | 5 (0.42) (0.64) | 2107.2 (<0.0001) |
| Gamma (P.1) | 155 (99.4) (0.38) | 1 (0.64) (0.63) | 0 | 152.0 (<0.0001) |
| Delta (B.1.617.2) | 37 552 (99.66) (91) | 47 (0.12) (29.74) | 82 (0.22) (10.5) | 74 590.0 (<0.0001) |
| Global χ2 (p value) | 8199.6 (<0.0001) | |||
| Clades | ||||
| G | 12 117 (96.2) (18.77) | 381 (3.02) (27.43) | 103 (0.82) (7.25) | 22 390 (<0.0001)* |
| GH | 3824 (83.9) (5.92) | 634 (13.9) (45.64) | 98 (2.2) (6.90) | 5343.8 (<0.0001)* |
| GR | 6843 (87.3) (10.60) | 37 (0.47) (2.66) | 956 (12.2) (67.32) | 10 441.9 (<0.0001)* |
| GRY | 941 (88.5) (1.46) | 66 (6.2) (4.75) | 56 (5.27) (3.94) | 1457.1 (<0.0001)* |
| GV | 100 (62.5) (0.15) | 57 (35.6) (4.10) | 3 (1.89) (0.21) | 88.6 (<0.0001)* |
| L | 63 (44.1) (0.10) | 79 (55.2) (5.69) | 1 (0.70) (0.07) | 71.2 (<0.0001)* |
| O | 1550 (90.2) (2.40) | 52 (3.03) (3.74) | 116 (6.8) (8.17) | 2505.5 (<0.0001)* |
| S | 397 (92.97) (0.61) | 28 (6.6) (2.02) | 2 (0.47) (0.14) | 685.8 (<0.0001)* |
| V | 164 (93.7) (0.25) | 8 (4.6) (0.58) | 3 (1.7) (0.21) | 287.3. (<0.0001)* |
| GK | 38 568 (99.7) (59.73) | 47 (0.12) (3.38) | 82 (0.21) (5.77) | 766.21 (<0.0001)* |
| Global χ2 (p value) | 11 981(<0.0001)* | |||
| Variant of interest | ||||
| Epsilon | 0 | 0 | 0 | NA |
| Zeta | 3 (100) (2.8) | 0 | 0 | NA |
| Eta | 89 (61.4) (82.4) | 56 (38.2) (100) | 0 | NA |
| Theta | 0 | 0 | 0 | NA |
| Lota | 0 | 0 | 0 | NA |
| Kappa | 16 (100) (14.8) | 0 | 0 | NA |
| Lambda | 0 | 0 | 0 | NA |
*P<0.05 considered statistically significant.
MENA, Middle East and North Africa; NA, not applicable.